Project Details
Abstract
Shuttling of specific proteins into (import) and out (export) of the nucleus, termed
nucleocytoplasmic transport is essential for the precise regulation of cellular processes in normal
and also malignant cells. Karyopherin alpha 2 (KPNA2, importin α1) delivers classical nuclear
localization sequence (cNLS)-containing cargo proteins to the nucleus, followed by translocation
back into cytoplasmic compartments. Aberrant KPNA2 expression has been observed in numerous
types of human cancer tissues and is associated with poor prognosis in patients. Previously, we
identified KPNA2 as a potential biomarker for non-small cell lung cancer (NSCLC) [1]. We also
identified E2F1 as a novel cargo of KPNA2 [2] and we have demonstrated that the high level of
KPNA2-vimentin-pErk complex was associated with lung cancer invasiveness [3]. Nevertheless,
the upstream signal responsible for KPNA2 overexpression and its nuclear accumulation in
cancer cells remain unclear. Whether KPNA2 can serve the novel roles which are different
from its well-known nuclear transport is also need to be clarified. In this proposal, we aim to
study the upstream signaling, the transcriptional regulation and the molecular mechanisms
responsible for the dysregulated KPNA2 in cancer cells. Our preliminary data show that 1)
mTOR signaling modulated KPNA2 expression in lung and breast cancer cells; 2) E2F1/Dp1 and
IRF1 were potential transcription factors (TFs) responsible for KPNA2 gene expression; 3) EGF
and oxidative stress induced the nuclear accumulation and complex formation of KPNA2 in cancer
cells; 4) KPNA2 was identified as a multiple phosphorylated protein and the phosphorylation would
regulate its subcellular localization. Our hypothesis is that the post-translational modifications
(PTMs) as well as KPNA2-interacting proteins, both cNLS-containing and cNLS-free proteins
contribute to KPNA2-mediated tumorigenesis. The objective of this proposal is to understand the
fundamental basis of the spatiotemporal regulation of KPNA2 functional complexes formation and
to develop the potential therapeutic target to suppress KPNA2-mediated tumorigenesis.
Our specific aims include:
1. Investigate the upstream signaling and TFs responsible for KPNA2 overexpression in NSCLC.
2. Investigate the molecular mechanisms including PTMs and protein-protein interactions
responsible for nuclear accumulation of KPNA2 complexes in cancer cells.
3. Study the cargo-dependent and cargo-independent mechanisms of KPNA2-mediated
tumorigenesis.
4. Search the potential therapeutic targets to specifically suppress overexpression or attenuate
nuclear import through KPNA2 in cancer cells.
The expected impact on social and academic development after the implementation of this project
include: (1) it will help our understanding of the underling mechanisms of KPNA2 overexpression
in human cancers; (2) it provides the knowledge and methods applied to study the spatiotemporal
regulation of KPNA2 complex formation and its role in tumorigenesis; (3) it provides the basis to
develop a novel therapeutic target of cancer by modulating the nucleocytoplasmic transport.
Project IDs
Project ID:PC10601-1055
External Project ID:MOST105-2320-B182-035-MY3
External Project ID:MOST105-2320-B182-035-MY3
Status | Finished |
---|---|
Effective start/end date | 01/08/17 → 31/07/18 |
Keywords
- KPNA2
- lung cancer
- nucleocytoplasmic transport
- proteomic
- protein complex
- PTMs
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.